Standard dosing ranges from 2-5mg administered subcutaneously two to three times weekly
KLOW is a research-grade peptide blend combining TB-500, BPC-157, GHK-Cu, and
If you are pregnant, breastfeeding, have a medical condition, or are taking any medications, please consult with a healthcare professional before use
Retatrutide is at the Phase 3 stage, and the cagrilintide-plus-semaglutide combination CagriSema was reported to have a New Drug Application under FDA review, but a filing under review is not an approval
Key Takeaway: While glutathione is the primary driver for skin whitening, supporting it with omega-3s and molecular hydrogen can improve overall skin texture and cellular resilience
Injectable dose: 1-2mg daily subcutaneous Optional topical: 0.5-2% solution to problem areas Timing: Any time of day, food intake does not affect absorption Cycle length: 8-12 weeks on, 4-6 weeks off When to start: After 15-20lb weight loss or preemptively TB-500: Systemic Recovery and Inflammation Thymosin Beta-4 fragment, commonly known as TB-500, provides whole-body recovery support through mechanisms distinct from other healing peptides
